Loading
A phase 2 trial of DNX-2401 run by Clinica Universidad de Navarra, Universidad de Navarra, now recruiting.
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors is a phase 2 interventional study registered as NCT07424092 by Clinica Universidad de Navarra, Universidad de Navarra, with 39 participants planned, started 2026-05-12. Conditions recorded: High Grade Glioma, Ependymoma, Embryonal Tumor of Brain, Recurrence, Refractory, Pediatric and Young Adult. Interventions recorded: DNX-2401.
Shares DNX-2401, DNAtrix, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares DNX-2401, DNAtrix, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares DNX-2401, DNAtrix, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares DNX-2401, DNAtrix, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares DNX-2401, DNAtrix, Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/